-
1
-
-
11944275668
-
Etoposide in acute non-lymphocytic leukaemia (ANLL)
-
(1990)
Blood
, vol.75
, pp. 1-6
-
-
Bishop, J.F.1
Lowenthal, R.M.2
Joshua, D.3
Matthews, J.P.4
Todd, D.5
Cobcroft, R.6
Whiteside, M.7
Kronenberg, H.8
Ma, D.9
Dodds, A.10
Herrmann, R.11
Szer, J.12
Wolf, M.M.13
Young, G.14
-
2
-
-
9044228414
-
A randomized study of high-dose cytarabine in induction in acute myeloid leukaemia
-
(1996)
Blood
, vol.87
, pp. 1710-1717
-
-
Bishop, J.1
Matthews, J.2
Young, G.3
Szer, J.4
Gillett, A.5
Joshua, D.6
Bradstock, K.7
Enno, A.8
Wolf, M.9
Fox, R.10
Cobcroft, R.11
Herrmann, R.12
van Der Weyden, M.13
Lowenthal, R.M.14
Page, F.15
Garson, O.M.16
Juneja, S.17
-
3
-
-
0023945042
-
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
-
(1988)
N Engl J Med
, vol.318
, pp. 1414-1422
-
-
Gabrilove, J.L.1
Jakubowski, A.2
Scher, H.3
Sternberg, C.4
Wong, G.5
Grous, J.6
Yagoda, A.7
Fain, K.8
Moore, M.A.S.9
Clarkson, B.10
Oettgen, H.F.11
Alton, K.12
Welte, K.13
Souza, L.14
-
4
-
-
0025800331
-
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
-
(1991)
N Engl J Med
, vol.325
, pp. 164-170
-
-
Crawford, J.1
Ozer, H.2
Stoller, R.3
Johnson, D.4
Lyman, G.5
Tabbara, I.6
Kris, M.7
Grous, J.8
Picozzi, V.9
Rausch, G.10
Smith, R.11
Gradishar, W.12
Yahanda, A.13
Vincent, M.14
Stewart, M.15
Glaspy, J.16
-
6
-
-
0025187881
-
Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia
-
(1990)
N Engl J Med
, vol.323
, pp. 871-877
-
-
Ohno, R.1
Tomonaga, M.2
Kobayashi, T.3
Kanamuru, A.4
Shirakawa, S.5
Masaoka, T.6
Omine, M.7
Oh, H.8
Nomura, T.9
Sakai, Y.10
Hirano, M.11
Yokomaku, S.12
Nakayama, S.13
Yoshida, Y.14
Miura, A.B.15
Morishima, Y.16
Dohy, H.17
Niho, Y.18
Hamajima, N.19
Takaku, F.20
more..
-
7
-
-
0028256428
-
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia
-
and the Kohseisho Leukemia Study Group
-
(1994)
Blood
, vol.83
, pp. 2086-2092
-
-
Ohno, R.1
Naoe, T.2
Kanamaru, A.3
Yoshida, M.4
Hiraoka, A.5
Kobayashi, T.6
Ueda, T.7
Minami, S.8
Morishima, Y.9
Saito, Y.10
Furusawa, S.11
Imai, K.12
Takemoto, Y.13
Miura, Y.14
Teshima, H.15
Hamajima, N.16
-
8
-
-
0002649091
-
GM-CSF multiple course priming and long-term administration in newly diagnosed AML. Hematopoietic and therapeutic effects
-
Abstr.
-
(1994)
Blood
, vol.84
, Issue.SUPPL. 1
-
-
Buchner, T.1
Hiddemann, W.2
Wormann, B.3
Rottmann, R.4
Zuhlsdorf, M.5
Maschmeyer, G.6
Ludwig, W.D.7
Sauerland, M.C.8
Frisch, J.9
Schulz, G.10
-
9
-
-
0028959505
-
GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML)
-
(1995)
Leukemia
, vol.5
, pp. 3-9
-
-
Heil, G.1
Chadid, L.2
Hoelzer, D.3
Seipelt, G.4
Mitrou, P.5
Huber, C.6
Kolbe, K.7
Mertelsmann, R.8
Lindermann, A.9
Frisch, J.10
Nicolay, U.11
Gaus, W.12
Heimpel, H.13
-
10
-
-
0029015209
-
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55-70 years of age) with acute myelogenous leukemia
-
A study of the Eastern Cooperative Oncology Group (ECOG)
-
(1995)
Blood
, vol.86
, pp. 457-462
-
-
Rowe, J.M.1
Andersen, J.2
Mazza, J.J.3
Bennett, J.M.4
Paietta, E.5
Hayes, A.6
Oette, D.7
Cassileth, P.A.8
Stadtmauer, E.A.9
Wiernik, P.H.10
-
11
-
-
0003860788
-
GM-CSF during and after remission induction treatment for elderly patients with acute myeloid leukemia (AML)
-
Abstr.
-
(1995)
Blood
, vol.86
, Issue.SUPPL. 1
-
-
Witz, F.1
Harousseau, J.L.2
Sadoun, A.3
Guyotat, D.4
Berthou, C.5
Cahn, J.Y.6
Gardin, C.7
Lioure, B.8
Witz, B.9
Desablens, B.10
Ifrah, N.11
Pignon, B.12
Leprise, P.Y.13
Audhuy, B.14
Caillot, D.15
Casassus, P.16
Linassier, P.17
Christian, B.18
Hurteloup, P.19
Polin, V.20
Tellier, Z.21
more..
-
12
-
-
0003798020
-
Various modalities of use of GM-CSF in the treatment of acute myelogenous leukemia (AML). A Hovon-sakk randomized study (HOVON-4A)
-
Abstr.
-
(1995)
Blood
, vol.86
, Issue.SUPPL. 1
-
-
Lowenberg, B.1
Boogaerts, M.A.2
Vellenga, E.3
Ossenkoppele, G.J.4
Dekker, A.W.5
van der Lelie, J.6
Schouten, H.C.7
Fopp, M.8
Gratwohl, A.9
Fey, M.10
Gmur, J.11
van Putten, W.J.L.12
-
13
-
-
0004522594
-
GM-CSF during as well as after induction chemotherapy (CT) in elderly patients with acute myeloid leukemia (AML). The EORTC-HOVON Phase III Trial (AML 11)
-
Abstr.
-
(1995)
Blood
, vol.86
, Issue.SUPPL. 1
-
-
Lowenberg, B.1
Suciu, S.2
Zittoun, R.3
Ossenkoppele, G.J.4
Boogaerts, M.5
Wijermans, P.W.6
Vellenga, E.7
Berneman, Z.N.8
Dekker, A.W.9
Sonneveld, P.10
Stryckmans, P.11
Solbu, G.12
Dardenne, M.13
de Witte, T.14
Archimbaud, E.15
-
14
-
-
0029033064
-
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia
-
Cancer and Leukemia Group B
-
(1995)
N Engl J Med
, vol.332
, pp. 1671-1677
-
-
Stone, R.M.1
Berg, D.T.2
George, S.L.3
Dodge, R.K.4
Paciucci, P.A.5
Schulman, P.6
Lee, E.J.7
Moore, J.O.8
Powell, B.L.9
Schiffer, C.A.10
-
16
-
-
0029068452
-
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia
-
(1995)
N Engl J Med
, vol.332
, pp. 1678-1683
-
-
Dombret, H.1
Chastang, C.2
Fenaux, P.3
Reiffers, J.4
Bordessoule, D.5
Bouabdallah, R.6
Mandelli, F.7
Ferrant, A.8
Auzanneau, G.9
Tilly, H.10
Yver, A.11
Degos, L.12
-
17
-
-
8944234342
-
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: A randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group
-
(1996)
J Clin Oncol
, vol.14
, pp. 2150-2159
-
-
Zittoun, R.1
Suciu, S.2
Mandelli, F.3
de Witte, T.4
Thaler, J.5
Stryckmans, P.6
Hayat, M.7
Peetermans, M.8
Cadiou, M.9
Solbu, G.10
Petti, M.C.11
Willemze, R.12
-
18
-
-
6844251615
-
A randomized, double-blind, placebo controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia
-
for the International Acute Myeloid Leukemia Study Group
-
(1997)
Blood
, vol.90
, pp. 4710-4718
-
-
Heil, G.1
Hoelzer, D.2
Sanz, M.A.3
Lechner, K.4
Yin, J.A.L.5
Papa, G.6
Noens, L.7
Szer, J.8
Ganser, A.9
O'Brien, C.10
Matcham, J.11
Barge, A.12
-
22
-
-
0028344644
-
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with cytarabine without granulocyte colony-stimulating factor
-
(1994)
J Clin Oncol
, vol.12
, pp. 671-678
-
-
Estey, E.1
Thall, P.2
Andreeff, M.3
Beran, M.4
Kantarjian, H.5
O'Brien, S.6
Escudier, S.7
Robertson, L.E.8
Koller, C.9
Kornblau, S.10
Pierce, S.11
Freireich, E.J.12
Deisseroth, A.13
Keating, M.14
-
24
-
-
0007656213
-
Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia
-
(1996)
Blood
, vol.88
, Issue.SUPPL. 1
-
-
Lu, Z.J.1
Luo, R.2
Erder, H.3
Heil, G.4
Ganser, A.5
Lechner, K.6
Yin, J.L.7
Szer, J.8
Barge, A.9
-
26
-
-
0033061781
-
Economic analysis of a randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia
-
for the Eastern Cooperative Oncology Group (E1490)
-
(1999)
Ann Oncol
, vol.10
, pp. 177-182
-
-
Bennett, C.L.1
Stinson, T.J.2
Tallman, M.S.3
Stadtmauer, E.A.4
Marsh, R.W.5
Friedenberg, W.6
Lazarus, H.M.7
Kaminer, L.8
Golub, R.M.9
Rowe, J.M.10
-
28
-
-
0023575978
-
The importance of dose and dose intensity in lung cancer chemotherapy
-
(1987)
Semin Oncol
, vol.14
, Issue.SUPPL. 4
, pp. 20-28
-
-
Murray, N.1
|